Faculty, Staff and Student Publications
Publication Date
9-1-2025
Journal
Journal of Clinical Medicine
DOI
10.3390/jcm14176177
PMID
40943937
PMCID
PMC12429164
PubMedCentral® Posted Date
9-25-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Peripartum depression (PPD) represents a significant public health concern, affecting 10-17% of women globally. Traditional monoaminergic treatments demonstrate limited efficacy and delayed onset of action. The glutamate-GABA imbalance hypothesis provides a novel theoretical framework for understanding depression pathophysiology and developing targeted therapeutic interventions. This review examines emerging pharmacotherapeutic approaches targeting glutamatergic and GABAergic neurotransmitter systems for PPD treatment. Search criteria targeted randomized clinical trials investigating GABA-A-positive allosteric modulators (brexanolone, zuranolone, and ganaxolone) and NMDA receptor antagonists (ketamine and esketamine) in PPD patients. Brexanolone was the first neurosteroid to receive FDA approval for PPD, while zuranolone also shows promise. Ketamine and esketamine are also associated with reduced PPD risk, particularly with perioperative administration during cesarean delivery, though benefits are predominantly short-term. These glutamate-GABA pathway modulators represent novel therapeutic alternatives with rapid onset profiles. Further investigation and research are needed to optimize dosing protocols and patient selection criteria and to establish long-term efficacy before PPD treatment guidelines can be drafted.
Keywords
peripartum depression, postpartum depression, GABA, glutamate, pharmacotherapies, psychopharmacology
Published Open-Access
yes
Recommended Citation
Courtes, Alan C; Smitherman, Louisa; Shahani, Lokesh; et al., "Peripartum Depression Pharmacotherapies Targeting GABA-Glutamate Neurotransmission" (2025). Faculty, Staff and Student Publications. 5017.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5017
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons